Skip to main content

Table 1 Physician characteristics

From: Unmet needs in the treatment of idiopathic pulmonary fibrosis―insights from patient chart review in five European countries

Factor, n (%)

Physicians N = 290

Countrya

 Germany

60 (20.7)

 France

51 (17.6)

 Italy

70 (24.1)

 United Kingdom (UK)

49 (16.9)

 Spain

60 (20.7)

Type of practice

 General hospital

157 (54.1)

 Centre specializing in lung diseases

120 (41.4)

 Office-based practice

42 (14.5)

MDT available

213 (73.4)

 MDT team members

  Respiratory specialist/pulmonologist

212 (99.5)

  Radiologist

206 (96.7)

  Pathologist

165 (77.5)

  ILD/IPF Specialist Nurse

70 (32.9)

  Other

44 (20.7)

Expert center (France, Germany, and Spain)a

90/171 (52.6)

 General University Hospital with >60 patients and MDTb

40 (23.4)

 Office-based physicians with >60 patients and MDT

5 (2.9)

 Lung clinic with MDT availableb

47 (27.5)

Expert center (UK and Italy)a

 Authorized to prescribe pirfenidone

80/119 (67.2)

  1. For individual questions asked, please refer to Additional files 1 and 2
  2. MDT multidisciplinary team, ILD interstitial lung disease, IPF, idiopathic pulmonary fibrosis
  3. aUnweighted data
  4. bTwo centers qualified under both criteria